To Get Help Now
Click Here
 
Today's Date:

Class Action Filed After DMAA Warning

AddThis Social Bookmark Button

Anthony Velasco has filed a class action lawsuit against SEI Pharmaceuticals alleging that the DMAA-containting product MethylHex 4,2 is “illegal and dangerous” and that millions of dollars have been taken from consumers because of the company’s fraudulent behavior, Natural Products Insider reports.

The class action lawsuit is one of several filed following a warning by the FDA regarding DMAA (dimethylamylamine). The U.S. Food and Drug Administration “issued warning letters to ten manufacturers and distributors of dietary supplements containing dimethylamylamine, more popularly known as DMAA, for marketing products for which evidence of the safety of the product had not been submitted to FDA. Also referred to as 1,3-dimethylamylamine, methylhexanamine, or geranium extract, the ingredient is in dietary supplements and is often touted as a “natural” stimulant,” the FDA website said.

“The FDA letters noted that DMAA is known to narrow the blood vessels and arteries, which can elevate blood pressure and may lead to cardiovascular events ranging from shortness of breath and tightening in the chest to heart attack. The agency has received 42 adverse event reports on products containing DMAA. While the complaints do not establish that DMAA was the cause of the incidents, some of the reports have included cardiac disorders, nervous system disorders, psychiatric disorders, and death.”

The Velasco lawsuit also charges SEI with failing to warn consumers about the dangers associated with the synthetic chemical.

breakinglawsuitnews.com disclaimer: This article: Class Action Filed After DMAA Warning was posted on Friday, May 4th, 2012 at 1:00 am at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Comments are closed.